Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Early Pregnancy HbA1c in Predicting Excessive Fetal Growth in Women at Risk of Glucose Intolerance

NCT04858386 is registered in ClinicalTrials.gov with Belfast Health and Social Care Trust as lead sponsor.

NCT NCT04858386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04858386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Early Pregnancy HbA1c in Predicting Excessive Fetal Growth in Women at Risk of Glucose Intolerance
Lead sponsor
Belfast Health and Social Care Trust
Phase
Observational
Overall status
Terminated
Start date
November 1, 2017
Completion date
August 4, 2020
Enrollment
1,314 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes